IP Group's Avacta signs $180m deal with LG Chem
10th Dec 2018 07:24
(Sharecast News) - IP Group's AIM-listed portfolio company Avacta Group has agreed an 'Affimer' therapeutics development partnership and license agreement with LG Chem Life Sciences, part of the South Korean LG Group chaebol, worth up to $180m across upfront, near-term payments and development milestones, it was announced on Monday.
Read moreFTSE 250 movers: Oilers rise on OPEC agreement while Sirius dives
7th Dec 2018 14:42
(Sharecast News) - London's FTSE 250 was up 1.15% at 17,957.43 in afternoon trade on Friday, as oilers powered upward on the back of an OPEC decision to cut production.
Read moreWednesday broker round-up
5th Dec 2018 11:18
(Sharecast News) - Ted Baker: HSBC downgrades to hold with a target price of 1,450p.
Read moreIP Group's Ultrahaptics raises £35m in new funding round
3rd Dec 2018 07:42
(Sharecast News) - Intellectual property-based business developer IP Group said on Monday that its portfolio company Ultrahaptics, which uses haptics technology to create sensations of touch in mid-air, had completed a £35.0m fundraising.
Read moreFriday broker round-up
19th Oct 2018 13:10
(Sharecast News) - IP Group: Berenberg reiterates buy with a target price of 160p.
Read moreBerenberg initiates IP Group at 'buy'
19th Oct 2018 12:37
(Sharecast News) - Berenberg initiated coverage on intellectual property-based business developer IP Group on Friday, saying that it now believes the group's portfolio was the "most mature" it had been in its eighteen-year history.
Read moreIP Group puts another £3.8m into cybersecurity firm Garrison
15th Oct 2018 15:50
(Sharecast News) - Intellectual property-based business developer IP Group said on Monday that its portfolio company Garrison Technology, a specialist provider of "ultra-secure" web browsing technology, has completed a £22.9m fundraising.
Read moreDiurnal's endocrine drug does not meet trial objective
8th Oct 2018 09:29
(Sharecast News) - Clinical trials of Diurnal Group's Chronocort drug failed to meet the primary objective of proving superior to conventional therapy in endocrine control over a 24-hour period.
Read moreIP Group appoints Douglas Flint as chairman
17th Sep 2018 07:19
(Sharecast News) - IP Group has appointed Sir Douglas Flint as non-executive chairman and director of the company.
Read moreIP Group pours cash into Genomics Series B round
30th Aug 2018 09:45
(Sharecast News) - Intellectual property-based business developer IP Group announced on Thursday that its portfolio company Genomics has confirmed that Vertex Pharmaceuticals has led an oversubscribed £25m Series B financing round, and signed a three-year collaboration agreement.
Read moreCeres Power enters strategic collaboration with Bosch
21st Aug 2018 08:00
(Sharecast News) - Fuel cell developer Ceres Power Holdings has agreed a strategic collaboration with German engineering giant Robert Bosch, as well as a £9.0m strategic equity investment by Bosch into Ceres.
Read moreIP Group describes first half performance as 'robust'
25th Jul 2018 08:28
(Sharecast News) - Intellectual property-based business developer IP Group announced its half-yearly results for the six months ended 30 June on Wednesday, reporting net portfolio gains of £0.7m, down from £28.7m at the same time last year.
Read moreIP Group portfolio companies raise £5.4m
6th Feb 2017 07:17
(ShareCast News) - IP Group, the developer of intellectual property-based businesses, said its first two portfolio companies from US university partners had raised a combined £5.4m ($6.8m) in new post seed financing rounds via private placement of ordinary shares. Exyn Technologies, a spin off from
Read moreIP Group completes takeover of Parkwalk Advisors
1st Feb 2017 08:31
(ShareCast News) - Intellectual property-based business developer IP Group announced on Wednesday the completion of its acquisition of Parkwalk Advisors, which was first announced on 16 December, following receipt of approval of a change of controller application from the Financial Conduct Authority
Read moreIP Group launches Microbiotica venture
19th Dec 2016 07:13
(ShareCast News) - Intellectual property-based business developer IP Group announced the creation of Microbiotica on Monday, which it described as a newly formed spin-out company from the Wellcome Trust Sanger Institute established to commercialise the institute's research into the role of the human
Read more